Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 49
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    CRISPR Capsules: Packaging Cas9 with bacterial outer membrane vesicles

    NU iGEM is creating a delivery system for an innovative antibiotic method centered around CRISPR, a powerful...

    Cataloging Insect and Bat Diversity in Belize

    This project intends to create a major entomology collection housed in Belize and to conduct bat inventories...

    Backer Badge Funded